'Pre-synaptic' vesicular glutamate release mechanisms in osteoblasts

Area of Science:

• Bone biology
• Neurobiology
• Cellular signaling

Background:

• Intercellular signaling pathways in bone are crucial therapeutic targets for conditions like osteoporosis.
• Glutamate, an excitatory amino acid, mediates a signaling pathway in bone with similarities to synaptic neurotransmission.
• Bone cells express functional glutamate receptors involved in bone formation and resorption.

Purpose of the Study:

• To review the current understanding of presynaptic signaling mechanisms involving glutamate in bone.
• To present evidence for osteoblasts' capability in regulated vesicular glutamate release.
• To discuss alternative glutamate sources for receptor activation in osteoblasts.

Main Methods:

• Review of existing literature on glutamate signaling in bone.
• Analysis of evidence for vesicular glutamate release from osteoblasts.
• Discussion of physiological glutamate release in osteoblasts and osteoblastic cell lines.

Main Results:

• Osteoblasts possess the molecular machinery for regulated vesicular glutamate release.
• Evidence supports the physiological release of glutamate in various osteoblasts and osteoblastic cell lines.
• Similarities and differences between CNS and bone glutamatergic mechanisms are highlighted.

Conclusions:

• Osteoblasts can release glutamate in a regulated manner, similar to presynaptic neurons.
• Understanding glutamate's role in bone cell function may offer new therapeutic strategies for bone diseases.
• Further research into glutamate signaling in bone is warranted to define its precise role and regulatory control.